Cannabis and Cannabinoid Research

The endocannabinoid system is a signaling network found throughout the brain and body, built around two primary receptors — CB1 and CB2 — that respond to both naturally produced compounds and the active constituents of cannabis. Pharmacologists studying this system are working to understand how it regulates synaptic transmission, immune response, metabolism, and mood, with the goal of developing targeted therapies for conditions ranging from epilepsy and multiple sclerosis to anxiety and metabolic disorders. A central challenge is separating the therapeutic potential of specific cannabinoids from the psychiatric risks associated with broader cannabis use, particularly given evidence linking heavy use to psychosis and cognitive changes. Ongoing research is also asking whether drugs that modulate cannabinoid receptors more selectively than cannabis itself — without producing intoxication — can deliver clinical benefits while minimizing harm.

Works

93,356

Total citations

2,107,391

Keywords

Endocannabinoid SystemCannabinoid ReceptorsCannabis UseNeurological DisordersPsychiatric EffectsMetabolic Disorders